BIT
ENZN

BlackRock Institutional Trust’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

BlackRock Institutional Trust’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,834,816
Closed -$1.33M – 4019
2016
Q1 		$1.33M Sell
2,834,816
-32,915
-1% -$16.1K ﹤0.01% 3200
2015
Q4 		$1.96M Sell
2,867,731
-1,911
-0.1% -$1.51K ﹤0.01% 3130
2015
Q3 		$2.78M Sell
2,869,642
-11,816
-0.4% -$14.5K ﹤0.01% 2983
2015
Q2 		$3.46M Sell
2,881,458
-56,545
-2% -$72K ﹤0.01% 2896
2015
Q1 		$3.11M Sell
2,938,003
-94,348
-3% -$97.6K ﹤0.01% 2931
2014
Q4 		$3.31M Sell
3,032,351
-26,252
-0.9% -$27.6K ﹤0.01% 2900
2014
Q3 		$3.3M Sell
3,058,603
-79,737
-3% -$98.4K ﹤0.01% 2859
2014
Q2 		$3.26M Sell
3,138,340
-327,024
-9% -$312K ﹤0.01% 2969
2014
Q1 		$3.57M Buy
3,465,364
+354,236
+11% +$366K ﹤0.01% 2913
2013
Q4 		$3.61M Buy
3,111,128
+243,923
+9% +$376K ﹤0.01% 2921
2013
Q3 		$4.82M Buy
2,867,205
+172,657
+6% +$319K ﹤0.01% 2753
2013
Q2 		$5.39M Buy
+2,694,548
New +$7.89M ﹤0.01% 2668

Other funds holding ENZN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
MCM
Monarch Capital Management Fort Wayne, Indiana $436M AUM 26.61% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return

BlackRock Institutional Trust's ENZN Position: Q2 2016 in Review

BlackRock Institutional Trust sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q2 2016, closing a stake of 2,834,816 shares — an estimated $1.33M sold.

BlackRock Institutional Trust first reported a position in ENZN in Q2 2013 and held it in 12 quarters. The position peaked at $5.39M in Q2 2013. 10 funds tracked by Wall St. Rank hold ENZN as of Q2 2016.

  • BlackRock Institutional Trust reported no remaining ENZON PHARMACEUTICALS INC position as of Q2 2016 after selling out during the quarter.
  • BlackRock Institutional Trust sold 2,834,816 ENZON PHARMACEUTICALS INC shares in Q2 2016, an estimated $1.33M.
  • BlackRock Institutional Trust first reported a position in ENZON PHARMACEUTICALS INC in Q2 2013 and held it in 12 quarters.
  • BlackRock Institutional Trust's ENZON PHARMACEUTICALS INC position peaked at $5.39M in Q2 2013.
  • 10 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q2 2016.

Based on BlackRock Institutional Trust's 13F filing for Q2 2016, filed 10 Aug 2016.